0 CHECKOUT

Venezuela Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3511174
  • December 2015
  • Region: Venezuela
  • 100 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Calox International
  • Elmor
  • GlaxoSmithKline
  • Grupo Farma
  • Merck & Co
  • MORE

Price controls, high inflation, currency devaluation, import and foreign currency controls, as well as other structurally distorting policies in Venezuela will continue to plague the country's pharmaceutical market in 2016.

Headline Expenditure Projections
- Pharmaceuticals: VEB51.0bn (USD8.1bn) in 2014 to VEB88.7 bn (USD3.0bn) in 2015; +74.0% in local currency terms and -62.6% in US dollar terms. Forecast has been revised upward from Q415 due to updated macroeconomic considerations.

- Healthcare: VEB129.5bn (USD20.6bn) in 2014 to VEB230.9bn (USD7.9bn) in 2015; +78.3% in local currency terms and -61.7% in US dollar terms. Forecast has been revised downward from Q415 due to updated macroeconomic considerations.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Boehringer Ingelheim
  • Calox International
  • Elmor
  • GlaxoSmithKline
  • Grupo Farma
  • Merck & Co
  • MORE

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Venezuela 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Venezuela 2011-2019)

Prescription Drug
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Venezuela 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Venezuela 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Venezuela 2013-2019)

Key Risks To Forecast Scenario

Industry Risk/Reward Index

Americas Risk/Reward Index

Venezuela Risk/Reward Index

Reward

Risk

Market Overview

Epidemiology

Healthcare Sector
Table: Healthcare Resources (Venezuela 2009-2014)
Table: Healthcare Personnel (Venezuela 2009-2014)
Table: Healthcare Activity (Venezuela 2009-2014)

Research & Development

Regulatory Review

Intellectual Property

Biologics And Biosimilars

Pricing Regime

Reimbursement Regime

Competitive Landscape

Research-Based Industry

Generic Drugmakers

Pharmaceutical Distribution

Pharmaceutical Retail Sector

Company Profile

Boehringer Ingelheim

Calox International

Elmor

GlaxoSmithKline

Grupo Farma

Merck & Co

Novartis

Pfizer

Sanofi

Strides Latina (Sumifarma)

Demographic Forecast

Demographic Outlook 2015
Table: Population Headline Indicators (Venezuela 1990-2025)
Table: Key Population Ratios (Venezuela 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Venezuela 1990-2025)
Table: Population By Age Group (Venezuela 1990-2025)
Table: Population By Age Group % (Venezuela 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Boehringer Ingelheim
Calox International
Elmor
GlaxoSmithKline
Grupo Farma
Merck & Co
Novartis
Pfizer
Sanofi
Strides Latina (Sumifarma)

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.